Company Overview
American HealthCare Capital is pleased to introduce a wearable balance and mobility technology platform for sale. The Company is a domestic health technology firm commercializing a non-invasive wearable designed to support physical stability, gait, and mobility. It targets a broad demographic experiencing motor impairment, including aging populations and individuals with chronic neurological conditions. The enterprise is generating immediate revenue in the general wellness market while collecting data to support a potential future regulatory pathway for therapeutic applications.
Financial Overview
The Company is in the early commercialization phase, having sold more than 800 units between January and August 2026, with sales projected to increase through year-end during the holiday season. Historical company-provided financial statements show total income of approximately $57,000 in 2023, $130,000 in 2024, and $6,000 in 2025, with grants and development-related receipts included in the historical presentation. Management’s model forecasts revenue growth from approximately $500,000 in 2026 to approximately $16.3 million in 2029.
Key Platform or Business Highlights
The Company is commercializing a proprietary wearable device, manufactured in the USA, that utilizes research-backed stimulation technology and is supported by ongoing clinical development.
Current Performance: The business is experiencing accelerating top-line growth through an active waitlist pipeline and just-in-time manufacturing fulfillment and has recently begun generating recurring revenue.
Operational Scale: Ongoing development is focused on building automated quality-control pipelines, specialized biometric telemetry architectures, and predictive analytics infrastructure.
Long-Term Vision: The Company’s long-term roadmap contemplates an evolution from a standalone hardware manufacturer into a technology-enabled platform offering subscription-based services, predictive risk assessments, and physical health analytics.
Growth and Scalability Opportunities
Illustrative strategic opportunities include:
- Channel expansion through providers, physical therapy, senior care, payers, employers, military contracts, and benefits platforms, as well as cross-selling through a buyer’s existing customer base;
- Product evolution using additional sensing capabilities;
- Continued clinical and outcomes development; and
- Greater use of automation, shared services, and analytics.
Buyer Rationale
A strategic or institutional buyer may be able to accelerate commercial distribution, clinical validation, regulatory execution, manufacturing scale, customer support, and integration with existing healthcare workflows. The Company may be relevant as a product, technology, capability, or platform acquisition depending on the buyer’s customer base and operating infrastructure.
Transaction Overview
The asking price will be determined through discussion and negotiation.
The Sellers are seeking a strategic or financial partner for a majority-control investment or full acquisition that will provide the capital and resources needed to support the Company’s continued growth and commercialization. Depending on the transaction structure, the Sellers are open to retaining rollover equity and are willing to remain with the Company following the transaction if requested by the buyer. The specific transaction structure, valuation, management roles, and timing will be determined through discussion and negotiation.